A Randomized Trial Comparing Hypofractionated and Conventionally Fractionated Three-Dimensional External-Beam Radiotherapy for Localized Prostate Adenocarcinoma
Authors:
Open Access
- 10 November 2009
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 185 (11) , 715-721
Abstract
To compare acute gastrointestinal (GI) and genitourinary (GU) toxicity between patient groups with localized prostate adenocarcinoma, treated with conventionally fractionated (CFRT) and hypofractionated (HFRT) three-dimensional conformal external-beam radiotherapy (3D-CRT). 91 patients were enrolled into a randomized study with a minimum follow-up of 3 months. 44 men in the CFRT arm were irradiated with 74 Gy in 37 fractions at 2 Gy per fraction for 7.5 weeks. 47 men in the HFRT arm were treated with 57 Gy in 17 fractions for 3.5 weeks, given as 13 fractions of 3 Gy plus four fractions of 4.5 Gy. The clinical target volume (CTV) included the prostate and the base of seminal vesicles. The CTV-to-PTV (planning target volume) margin was 8–10 mm. Study patients had portal imaging and/or simulation performed on the first fractions and repeated at least weekly. No acute grade 3 or 4 toxicities were observed. The grade 2 GU acute toxicity proportion was significantly lower in the HFRT arm: 19.1% versus 47.7% (χ2-test, p = 0.003). The grade 2 GU acute toxicity-free survival was significantly better in the HFRT arm (log-rank test, p = 0.008). The median duration of overall GI acute toxicity was shorter with HFRT: 3 compared to 6 weeks with CFRT (median test, p = 0.017). In this first evaluation, the HFRT schedule is feasible and induces acceptable or even lower acute toxicity compared with the toxicities in the CFRT schedule. Extended follow-up is needed to justify this fractionation schedule’s safety in the long term.Keywords
This publication has 26 references indexed in Scilit:
- Acute Toxicity After Hypofractionated Conformal Radiotherapy for Localized Prostate Cancer: Nonrandomized Contemporary Comparison With Standard FractionationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility studyRadiation Oncology, 2007
- Transabdominal Ultrasonography, Computed Tomography and Electronic Portal Imaging for 3-Dimensional Conformal Radiotherapy for Prostate CancerStrahlentherapie und Onkologie, 2007
- Phase II Trial of Hypofractionated Image-Guided Intensity-Modulated Radiotherapy for Localized Prostate AdenocarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: Report on acute toxicityRadiotherapy and Oncology, 2006
- Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRTInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- A randomized trial comparing two fractionation schedules for patients with localized prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Reduction in Acute Morbidity Using Hypofractionated Intensity-Modulated Radiation Therapy Assisted with a Fluoroscopic Real-Time Tumor-Tracking System for Prostate CancerThe Cancer Journal, 2003
- HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995